Insider Transactions in Q4 2021 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Bona fide gift
|
Direct |
1,000
+1.71%
|
-
|
|
Dec 20
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.38%
|
-
|
|
Dec 20
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-5.12%
|
$3,873,450
$119.28 P/Share
|
|
Dec 20
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.52%
|
-
|
|
Dec 20
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|
|
Dec 17
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
10,000
-26.73%
|
$1,210,000
$121.24 P/Share
|
|
Dec 17
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.09%
|
$210,000
$21.76 P/Share
|
|
Dec 10
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-3.05%
|
$768,350
$121.75 P/Share
|
|
Dec 10
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Dec 10
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.28%
|
$1,337,050
$121.75 P/Share
|
|
Dec 10
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Dec 10
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-3.81%
|
$947,430
$121.49 P/Share
|
|
Dec 10
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+3.67%
|
$274,050
$35.2 P/Share
|
|
Nov 29
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
100
-0.07%
|
$11,000
$110.58 P/Share
|
|
Nov 29
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.07%
|
$2,100
$21.76 P/Share
|
|
Nov 24
2021
|
Nicholas J Valeriani Director |
BUY
Open market or private purchase
|
Direct |
1,500
+2.3%
|
$168,000
$112.23 P/Share
|
|
Nov 18
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
10,000
-9.59%
|
$1,170,000
$117.91 P/Share
|
|
Nov 18
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.09%
|
$210,000
$21.76 P/Share
|
|
Nov 10
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.06%
|
$931,770
$119.79 P/Share
|
|
Nov 10
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.02%
|
$274,050
$35.2 P/Share
|
|
Nov 09
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.39%
|
-
|
|
Nov 09
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-7.67%
|
$3,873,450
$119.93 P/Share
|
|
Nov 09
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.36%
|
-
|
|
Nov 09
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|
|
Nov 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$755,650
$119.4 P/Share
|
|
Nov 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Nov 05
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.54%
|
$1,292,850
$117.24 P/Share
|
|
Nov 05
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Oct 18
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
9,741
-13.83%
|
$1,071,510
$110.56 P/Share
|
|
Oct 18
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
9,741
+20.77%
|
$204,561
$21.76 P/Share
|
|
Oct 11
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.06%
|
$845,640
$108.0 P/Share
|
|
Oct 11
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.02%
|
$274,050
$35.2 P/Share
|
|
Oct 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$698,500
$110.91 P/Share
|
|
Oct 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Oct 08
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.2%
|
$1,215,500
$110.77 P/Share
|
|
Oct 08
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Oct 01
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.39%
|
-
|
|
Oct 01
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-5.11%
|
$3,645,600
$112.2 P/Share
|
|
Oct 01
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.37%
|
-
|
|
Oct 01
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|